Advanced in Hemorrhagic Proctocolitis

Dr. Robert Mccabe

Gastroenterology
22 Bramhall St, 
Portland, ME 
Advanced in Hemorrhagic Proctocolitis
22 Bramhall St, 
Portland, ME 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robert Mccabe is a Gastroenterologist in Portland, Maine. Dr. Mccabe is rated as an Advanced provider by MediFind in the treatment of Hemorrhagic Proctocolitis. His top areas of expertise are Crohn's Disease, Ulcerative Colitis, Hemorrhagic Proctocolitis, Endoscopy, and Gastrectomy.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles and participated in 4 clinical trials in the study of Hemorrhagic Proctocolitis.

Specialties
Gastroenterology
Licenses
Internal Medicine in ME
Hospital Affiliations
Mainehealth Pen Bay Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Options
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Metropolitan Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

MAINEHEALTH
22 Bramhall St, Portland, ME 04102
Other Locations
MAINEHEALTH
4 Glen Cove Dr, Rockport, ME 04856

Additional Areas of Focus

Dr. Mccabe has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
Open Label, Randomized, Multicenter, Comparative Effectiveness Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission in Patients With Crohn's Disease
Open Label, Randomized, Multicenter, Comparative Effectiveness Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission in Patients With Crohn's Disease
Enrollment Status: Completed
Publish Date: July 21, 2021
Intervention Type: Other
Study Phase: Not Applicable
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

12 Total Publications

Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry.
Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry.
Journal: Clinical and translational gastroenterology
Published: July 11, 2023
Similar Doctors
Distinguished in Hemorrhagic Proctocolitis
Dr. Francis P. Colizzo
Gastroenterology
Distinguished in Hemorrhagic Proctocolitis
Dr. Francis P. Colizzo
Gastroenterology
4 West Rd, Suite 3 B, 
Stratham, NH 
 (56.1 miles away)
603-772-0222
Languages Spoken:
English
See accepted insurances

Francis Colizzo is a Gastroenterologist in Stratham, New Hampshire. Dr. Colizzo is rated as a Distinguished provider by MediFind in the treatment of Hemorrhagic Proctocolitis. His top areas of expertise are Ulcerative Colitis, Hemorrhagic Proctocolitis, Crohn's Disease, Colonoscopy, and Endoscopy.

Advanced in Hemorrhagic Proctocolitis
Dr. Benjamin Potter
Gastroenterology
Advanced in Hemorrhagic Proctocolitis
Dr. Benjamin Potter
Gastroenterology

Portland Gastroenterology Associates PA

161 Marginal Way, 
Portland, ME 
 (1.0 miles away)
207-773-7964
Languages Spoken:
English
See accepted insurances

Benjamin Potter is a Gastroenterologist in Portland, Maine. Dr. Potter is rated as an Advanced provider by MediFind in the treatment of Hemorrhagic Proctocolitis. His top areas of expertise are Diverticular Disease, Barrett Esophagus, Hiatal Hernia, Endoscopy, and Colonoscopy.

Advanced in Hemorrhagic Proctocolitis
Dr. Gordon Millspaugh
Gastroenterology
Advanced in Hemorrhagic Proctocolitis
Dr. Gordon Millspaugh
Gastroenterology

Portland Gastroenterology Associates PA

161 Marginal Way, 
Portland, ME 
 (1.0 miles away)
207-773-7964
Languages Spoken:
English
See accepted insurances

Gordon Millspaugh is a Gastroenterologist in Portland, Maine. Dr. Millspaugh is rated as a Distinguished provider by MediFind in the treatment of Hemorrhagic Proctocolitis. His top areas of expertise are Crohn's Disease, Childhood Pancreatitis, Benign Esophageal Stricture, Endoscopy, and Gastrectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mccabe's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile